The oral microbiome is identified as one of the major microbial ecosystems in the human body and has the potential to impact our health in various ways. Dysbiosis in the oral microbiome can have both local effects (e.g., dental caries, periodontitis, gingivitis, oral cancers), as well as systemic effects (e.g., neurodegeneration, diabetes, cardiovascular disease).
Systemic diseases can arise when pathogenic bacteria present in the oral cavity translocate into the gut in the presence of oral-gut barrier disruption. Fortunately, through re-establishing symbiosis in the oral microbiome through dietary and lifestyle changes, many unfavorable symptoms can be reversed.
US BioTek uses quantitative PCR technology to accurately measure and quantify the microbiota of the oral cavity.
We use polymerase chain reaction (PCR) tests to qualitatively detect nucleic acid from various parasites, bacteria, and viruses. The RT-PCR platform is FDA-authorized and requires specialized equipment and personnel to identify DNA within cells. Polymerase chain reaction (PCR) is a relatively simple and widely used molecular biology technique to amplify and detect DNA and RNA sequences.
The use of PCR testing allows US BioTek to more precisely identify even the smallest amounts of markers within the oral samples providing accurate, reliable, and reproducible results.